open access

Vol 86, No 7 (2015)
ARTICLES
Get Citation

Human papilloma virus genotyping in women with abnormal cytology

Tomasz Olejniczak, Dorota Rabiega-Gmyrek, Joanna Niepsuj-Biniaś, Paweł Jachowski, Bogna Guglas-Bochyńska, Anna Latos-Bieleńska, Jakub Woźniak, Tomasz Opala
DOI: 10.17772/gp/58639
·
Ginekol Pol 2015;86(7).

open access

Vol 86, No 7 (2015)
ARTICLES

Abstract

Objective: To assess presence of HPV infection and identification of the most common HPV types in patients with abnormal cytology based on the Bethesda system (atypical squamous cells). Material and method: 81 women with abnormal cytology based on the Bethesda system (atypical squamous cells) were qualified for the study. Material was taken from the cervical canal, the vaginal portion of the cervix and the vagina onto a liquid medium to detect HPV DNA and genotyping of 19 most common oncogenic types of high and medium risk was performed with the Papillomastrip method and for HPV types 6 and 11 with the PCR method. Results: HPV was detected in 53 out of 81 examined women, which accounted for 66%. The most common HPV types were: 6/11 – 23 cases (43% of women with infection), 16 – 23 cases (43% of women with infection), 18 and 33 with 9 cases each (17% of women with infection). Coexistence of 6/11 with 16 or 18 – 13 concerned 15 patients (28% of women with infection) and presence of HPV 16 or 18 was detected in 28 cases (53% of women with infection). Positive HPV type contained in the quadrivalent vaccine against human papillomavirus 6/11 and 16 or 18 was detected in 38 patients (72% of women with infection). 40% of HPV positive women were infected with only one type of the virus, 26% - with two types and 23% with three types. Conclusion: In 81 women with abnormal cytology based on the Bethesda system (atypical squamous cells) within 66% of HPV positive results the most common were type 6/11 (of low oncogenic potential but responsible for anogenital warts) and type 16 of high oncogenic potential.

Abstract

Objective: To assess presence of HPV infection and identification of the most common HPV types in patients with abnormal cytology based on the Bethesda system (atypical squamous cells). Material and method: 81 women with abnormal cytology based on the Bethesda system (atypical squamous cells) were qualified for the study. Material was taken from the cervical canal, the vaginal portion of the cervix and the vagina onto a liquid medium to detect HPV DNA and genotyping of 19 most common oncogenic types of high and medium risk was performed with the Papillomastrip method and for HPV types 6 and 11 with the PCR method. Results: HPV was detected in 53 out of 81 examined women, which accounted for 66%. The most common HPV types were: 6/11 – 23 cases (43% of women with infection), 16 – 23 cases (43% of women with infection), 18 and 33 with 9 cases each (17% of women with infection). Coexistence of 6/11 with 16 or 18 – 13 concerned 15 patients (28% of women with infection) and presence of HPV 16 or 18 was detected in 28 cases (53% of women with infection). Positive HPV type contained in the quadrivalent vaccine against human papillomavirus 6/11 and 16 or 18 was detected in 38 patients (72% of women with infection). 40% of HPV positive women were infected with only one type of the virus, 26% - with two types and 23% with three types. Conclusion: In 81 women with abnormal cytology based on the Bethesda system (atypical squamous cells) within 66% of HPV positive results the most common were type 6/11 (of low oncogenic potential but responsible for anogenital warts) and type 16 of high oncogenic potential.
Get Citation

Keywords

HPV genotypes / abnormal cytology / koilocytes/ primary prevention for cervical cancer / HPV infections / the Bethesda system /

About this article
Title

Human papilloma virus genotyping in women with abnormal cytology

Journal

Ginekologia Polska

Issue

Vol 86, No 7 (2015)

DOI

10.17772/gp/58639

Bibliographic record

Ginekol Pol 2015;86(7).

Keywords

HPV genotypes / abnormal cytology / koilocytes/ primary prevention for cervical cancer / HPV infections / the Bethesda system /

Authors

Tomasz Olejniczak
Dorota Rabiega-Gmyrek
Joanna Niepsuj-Biniaś
Paweł Jachowski
Bogna Guglas-Bochyńska
Anna Latos-Bieleńska
Jakub Woźniak
Tomasz Opala

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl